Although the world has come a long way since HIV was first recognized, the goal of eradicating the virus once and for all has not yet been realized. Hope remains, however, as individuals in the health care sector continue to dedicate their efforts to at least achieving the 90-90-90 targets laid out by the United […]
Bending & Ending the HIV Epidemic: Are We on Track to Meet 90-90-90 Goals? Read More »
Since its launch in 2016, a hepatitis C elimination program in Iceland has treated approximately 56% to 70% of the estimated viremic population with direct-acting antivirals, according to a recently published update. “The idea was to offer DAAs to all HCV-positive patients within an entire population within a relatively short time frame and simultaneously initiate
Icelandic HCV elimination program treats majority of viremic population Read More »
Numerous studies have found that the use of potent combination anti-HIV therapy (ART) strengthens the immune system and overall health. ART does this by gradually reducing the amount of HIV produced to very low levels-commonly called “undetectable.” This then allows the immune system to partially repair itself. The benefit of ART is so profound that
A shift over time in the HIV ward of one of Canada’s largest hospitals Read More »
Oren Adamson received a prescription for pre-exposure prophylaxis treatment in July of last year. Also known as PrEP, the once daily pill is believed to reduce the risk of contracting HIV by more than 90 per cent. Health Canada approved PrEP in the form of the drug Truvada last year, but it has remained too
HIV pre-exposure drug approved for funding in B.C., but barriers remain Read More »
The decision comes just days after New Zealand subsidized PrEP Within 24 hours Australia is highly likely to be the next country to subsidize PrEP tomorrow. It will make it more affordable and accessible for people at risk of acquiring HIV. Sources have told Gay Star News that Australian HIV organizations are feeling very confident
Australia will likely make PrEP more affordable tomorrow Read More »
PrEP may be free now, but who can access it? Soon after Nagata Prescott began dating an HIV-positive man, he received a rare offer. He could take a drug that would prevent him from contracting the virus – for free. This was two months before the BC government agreed to pay for the pre-exposure prophylaxis
Why HIV prevention is still out of reach for many people in rural BC Read More »
In this week’s brief tour of recently published research, we get a new glimpse into the huge successes of Vancouver’s years-long effort to reduce harm and increase HIV-related services among injection drug users. We also learn about the relative safety of stem-cell transplantation in people with HIV, the ability of certain biomarkers to predict future
This Week in HIV Research: To Seek and to Treat Read More »
Although Northern Health’s overall trend in newly identified HIV diagnoses has been declining since it peaked in 2004, there are still about 10 newly identified cases every year in the region. Between 2010 and 2014, there were 76 new cases of HIV infections in the Northern Health region. Since 2014, there have been 33 new
About 10 new HIV infections a year in northern B.C. Read More »
People with HIV over the age of 50 are more likely to have developed type 2 diabetes if they started antiretroviral treatment before 1999 or had a longer exposure to older antiretroviral drugs such as stavudine (d4T) or first-generation protease inhibitors such as nelfinavir or indinavir, according to a study of people receiving HIV care
Daily prevention pill was available previously but it was not covered, and high prices made it inaccessible People at high risk of becoming infected with the HIV virus will soon be able to access free medication to protect against it in B.C. Starting on Jan. 1, the province of British Columbia will cover the costs
‘We’ve been waiting for this for a long time’: B.C. to fund HIV-prevention drug Read More »
During the Canada Post strike announced September 25, 2025, the following measures will be undertaken to minimize service disruption to BC-CfE clients and providers.
During the Canada Post strike, we recommend that documents be faxed or couriered to our sites, versus utilization of regular mail service
The BC-CfE Laboratory is streamlining reporting processes for certain tests in order to simplify distribution and record-keeping, and to ensure completeness of results. Beginning September 2, 2025, results for the ‘Resistance Analysis of HIV-1 Protease and Reverse Transcriptase’ (Protease-RT) and ‘HIV-1 Integrase Resistance Genotype’ tests will be combined into a single ‘HIV-1 Resistance Genotype Report’.
For more details and example reports, please click on the button below
